These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 22024532)
1. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532 [TBL] [Abstract][Full Text] [Related]
2. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290 [TBL] [Abstract][Full Text] [Related]
3. Budget-Impact Analysis of Alternative Herpes Zoster Vaccine Strategies: A U.S. HMO Perspective. Graham J; Mauskopf J; Kawai K; Johnson KD; Xu R; Acosta CJ J Manag Care Spec Pharm; 2016 Jul; 22(7):872-88. PubMed ID: 27348287 [TBL] [Abstract][Full Text] [Related]
4. Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases. Yun H; Xie F; Baddley JW; Winthrop K; Saag KG; Curtis JR J Rheumatol; 2017 Jul; 44(7):1083-1087. PubMed ID: 28298565 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated? Safonova E; Yawn BP; Welte T; Wang C Respir Res; 2023 Jan; 24(1):35. PubMed ID: 36709298 [TBL] [Abstract][Full Text] [Related]
6. Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination. Yun H; Yang S; Chen L; Xie F; Winthrop K; Baddley JW; Saag KG; Singh J; Curtis JR Arthritis Rheumatol; 2016 Sep; 68(9):2328-37. PubMed ID: 26990731 [TBL] [Abstract][Full Text] [Related]
7. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400 [TBL] [Abstract][Full Text] [Related]
8. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications. Khan N; Shah Y; Trivedi C; Lewis JD Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309 [TBL] [Abstract][Full Text] [Related]
9. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases. Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine. Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States. Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049 [TBL] [Abstract][Full Text] [Related]
13. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757 [TBL] [Abstract][Full Text] [Related]
14. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194 [TBL] [Abstract][Full Text] [Related]
16. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. Langan SM; Smeeth L; Margolis DJ; Thomas SL PLoS Med; 2013; 10(4):e1001420. PubMed ID: 23585738 [TBL] [Abstract][Full Text] [Related]
17. Vaccination: a new option to reduce the burden of herpes zoster. Mick G Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Recombinant Zoster Vaccine in Patients With Inflammatory Bowel Disease. Khan N; Wang L; Trivedi C; Pernes T; Patel M; Xie D; Yang YX Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1570-1578.e1. PubMed ID: 34274513 [TBL] [Abstract][Full Text] [Related]
19. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status. Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911 [TBL] [Abstract][Full Text] [Related]
20. Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom. Matthews I; Lu X; Dawson H; Bricout H; O'Hanlon H; Yu E; Nozad B Vaccine; 2018 Nov; 36(46):7105-7111. PubMed ID: 30195489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]